C
ClearPoint Neuro, Inc. (CLPT)
NCM – Real Time Price. Currency in USD
12.64
+0.33 (2.68%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
12.64
+0.33 (2.68%)
At close: May 12, 2026, 4:00 PM EDT
ClearPoint Neuro, Inc., a commercial-stage medical device company, focuses on the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain in the United States. The company offers ClearPoint systems, such as ClearPoint hardware, which includes head fixation frame, computer workstation, and in-room monitor; and ClearPoint disposables, which consist of SmartFrame trajectory device, a hand controller and related accessories, and its SmartFlow Neuro cannula. It also provides ClearPoint software, which guides the physician in surgical planning, device alignment, navigation to the target, and procedure monitoring; ClearPoint Prism Neuro laser therapy system to necrotize or coagulate soft tissue; and IRRAflow system, an active fluid exchange platform. In addition, the company offers consulting services to its pharmaceutical and other medical technology partners, such as benchtop testing, preclinical studies, clinical trial support, regulatory consultation, and translation from the preclinical to the clinical setting. It has licenses and collaboration agreements with Koninklijke Philips N.V., UCB Biopharma SRL, Clinical Laserthermia Systems AB, University of California, San Francisco, and NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.
| Name | Position |
|---|---|
| Dr. Paul S. Larson FAANS, M.D. | Chief Medical Officer |
| Mr. Danilo D'Alessandro | Chief Financial Officer |
| Mr. Jeremy L. Stigall | Chief Business Officer |
| Mr. Joseph Michael Burnett | President, CEO & Director |
| Mr. Mazin Sabra | Chief Operating Officer |
| Mr. Robert C. Korn | Senior Vice President of Sales & Business Development |
| Date | Type | Document |
|---|---|---|
| 2026-04-23 | DEFA14A | clpt-20260423.htm |
| 2026-04-10 | DEF 14A | clpt-20260410.htm |
| 2026-03-17 | 10-K | clpt-20251231.htm |
| 2026-02-09 | S-8 | clpt-20260209.htm |
| 2026-02-05 | D | |
| 2026-02-05 | 8-K/A | clpt-20251120.htm |
| 2026-01-14 | S-3 | clearpoint_s3.htm |
| 2026-01-12 | 8-K | clpt-20260112.htm |
| 2026-01-05 | 8-K | clpt-20260105.htm |
| 2025-11-20 | 8-K | clpt-20251120.htm |
| Ms. Ellisa Cholapranee J.D. | General Counsel & Secretary |
| Ms. Mary McNamara-Cullinane RAC | Senior Vice President of Regulatory Affairs |
| Ms. Megan Faulkenberry | Senior Vice President of Quality |